HUBEI PROVINCE, CHINA--(MARKET WIRE)--Aug 15, 2007 -- Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTC BB:BPMA.OB - News), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced today that it has resumed production at its Jiangling Benda facility.
